US FDA Shies Away From Zoom Meetings Because Of Security Concerns
Uninvited guests already have accessed virtual meetings with sponsors using the application, raising concerns about the protection of proprietary information.
You may also be interested in...
Bubble was short-lived, but still could create workload problems for the US FDA as it navigates the end of the coronavirus pandemic.
Agency has created a centralized team to help review divisions with virtual advisory committee preparations and is trying to notify sponsors earlier in the review process about the need for a panel; sponsors cite importance of having a back channel of communications so team members can communicate with each other while an AdComm is underway.
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.